Dubduban, Baby Boy .

HRN: 23-07-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
CEFTAZIDIME 1GM (VIAL)
05/29/2023
06/04/2023
IV
96mg
Q12Hrs
Thickly MSAF
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: